Post-Traumatic Stress Disorder (PTSD) Clinical Trials

Find Post-Traumatic Stress Disorder (PTSD) Clinical Trials Near You

Targeted Plasticity Therapy for the Treatment of Post-Traumatic Stress Disorder

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Objectives of this study are to provide continued safety assessment for the ReStore system, and to gain further estimates of the effect size of Vagus Nerve Stimulation (VNS) therapy with Prolonged Exposure Therapy (PE) compared to PE with placebo (sham) stimulation in participants with posttraumatic stress disorder (PTSD)

Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Maximum Age: 79
Healthy Volunteers: f
View:

• Diagnosis of chronic PTSD for at least 3 months based on DSM-5 criteria

• In the medical opinion of the Principal Investigator (PI), failed at least one adequate course of first-line PTSD treatment per American Psychological Association (APA) guidelines

• PCL-5 score greater than 33

• Age 22-79 years

• Appropriate surgical candidate for VNS device implantation

• Willing and able to comply with study protocol

• Able to provide informed consent.

Locations
United States
Texas
The University of Texas Health Austin Ambulatory Surgery Center
RECRUITING
Austin
Baylor University Medical Center
RECRUITING
Dallas
Texas Biomedical Device Center
RECRUITING
Richardson
Contact Information
Primary
Amy Porter
alp160730@utdallas.edu
972-883-7256
Backup
Katharine Dlouhy
katharine.dlouhy@utdallas.edu
972-883-7231
Time Frame
Start Date: 2024-12-30
Estimated Completion Date: 2028-06
Participants
Target number of participants: 20
Treatments
Active_comparator: Immediate VNS Group
The participants in this arm will be implanted with the device and will receive active VNS stimulations in phase 1 as well as phase 2 of the study.
Sham_comparator: Delayed VNS Group
The participants in this arm will be implanted with the device but will receive sham VNS stimulations in phase 1 of the study and active VNS in phase 2 of the study.
Related Therapeutic Areas
Sponsors
Collaborators: The University of Texas Health Science Center at San Antonio, Congressionally Directed Medical Research Programs
Leads: The University of Texas at Dallas

This content was sourced from clinicaltrials.gov